animal model

动物模型
  • 文章类型: Journal Article
    在过去的十年中,精神药理学最重要的发展之一是针对情绪障碍的新型治疗方法的出现,如psilocybin治疗难治性抑郁症。Psilocybin最常见于不同种类的蘑菇;然而,有关具有潜在抗抑郁活性的蘑菇和真菌提取物的文献远远超出了含有psilocybin的蘑菇,包括迷幻和非迷幻物种。在当前的审查中,我们系统地回顾了蘑菇和真菌提取物的临床前文献,以及它们对抑郁症动物模型和抗抑郁活性测试的影响。PICO结构,PRISMA检查表和Cochrane干预措施系统评价手册被用来指导搜索策略。在电子数据库PubMed中进行了范围搜索,CINAHL,Embase和WebofScience。文献检索确定了50项相关和合适的已发表研究。其中包括19种不同的蘑菇,以及其他七种不同的真菌。几乎所有研究都报道了提取物治疗的抗抑郁作用。治疗最常见的是口服,在对主要是雄性啮齿动物的急性和长期给药研究中。使用了多种抑郁症动物模型,最常见的是不可预测的慢性轻度压力,而尾部悬吊试验和强迫游泳试验最常用作独立的抗抑郁药筛选。详细讨论了蘑菇和真菌物种的每个实验的细节,同时对这些研究的优缺点进行了评估。
    One of the most important developments in psychopharmacology in the past decade has been the emergence of novel treatments for mood disorders, such as psilocybin for treatment-resistant depression. Psilocybin is most commonly found in different species of mushroom; however, the literature on mushroom and fungus extracts with potential antidepressant activity extends well beyond just psilocybin-containing mushrooms, and includes both psychedelic and non-psychedelic species. In the current review, we systematically review the preclinical literature on mushroom and fungus extracts, and their effects of animal models of depression and tests of antidepressant activity. The PICO structure, PRISMA checklist and the Cochrane Handbook for systematic reviews of intervention were used to guide the search strategy. A scoping search was conducted in electronic databases PubMed, CINAHL, Embase and Web of Science. The literature search identified 50 relevant and suitable published studies. These included 19 different species of mushrooms, as well as seven different species of other fungi. Nearly all studies reported antidepressant-like effects of treatment with extracts. Treatments were most commonly delivered orally, in both acute and chronically administered studies to predominantly male rodents. Multiple animal models of depression were used, the most common being unpredictable chronic mild stress, while the tail suspension test and forced swim test were most frequently used as standalone antidepressant screens. Details on each experiment with mushroom and fungus species are discussed in detail, while an evaluation is provided of the strengths and weaknesses of these studies.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    子宫内膜异位症是女性的一种常见病,由于月经周期中子宫内膜组织在子宫外的生长而导致盆腔疼痛和生育问题。类固醇激素在子宫内膜异位症病变的发育和生长中起着至关重要的作用;因此,研究人员已经研究了几种有效的针对激素的药物来治疗这种疾病。一种这样的药物是巴泽多昔芬,但是尽管有几项动物研究,尚未对其合并结果进行全面评估。在几个数据库(Embase,PubMed,Scopus,和WebofSciences)以确定研究巴多昔芬在子宫内膜异位症动物模型中的有效性的研究。采用病例组和对照组给药前后子宫内膜异位症植入物大小进行Meta分析,以及关联的p值。Begg和Egger的测试用于评估发表偏倚。这项研究包括四个合格的研究,包括45个子宫内膜动物模型和35个对照受试者。荟萃分析显示,与对照组相比,bazedoxifene在动物模型中显着减小了子宫内膜异位症植入物的大小(比值比:0.122,95%置信区间:0.050-0.298,p<0.001)。详细调查确定研究之间没有明显的异质性(I2=38.81,Q检验的p值=0.179)。然而,根据Egger的测试,研究显示发表偏倚(p=0.035).这项研究发现,巴泽多昔芬是动物模型中子宫内膜异位症的有希望的治疗选择。然而,需要对动物和人类进行更多的研究来证实这些结果。
    Endometriosis is a prevalent condition in women that causes pelvic pain and fertility issues due to the growth of endometrial tissue outside the uterus during menstrual cycles. Steroid hormones play a crucial role in the development and growth of endometriosis lesions; therefore, researchers have investigated several effective drugs that target hormones for treating this disease. One such drug is bazedoxifene, but despite several animal studies, there has yet to be a comprehensive evaluation of their combined results. A systematic search was conducted across several databases (Embase, PubMed, Scopus, and Web of Sciences) to identify studies investigating the effectiveness of bazedoxifene in animal models of endometriosis. Meta-analysis was performed using the size of endometriosis implants before and after drug administration in the case and control groups, along with the p-value of the associations. Begg\'s and Egger\'s tests were used to assess publication bias. This study included four eligible studies consisting of 45 endometrial animal models and 35 control subjects. The meta-analysis showed that bazedoxifene significantly reduced the size of endometriosis implants in animal models compared with the control group (odds ratio: 0.122, 95% confidence interval: 0.050-0.298, p<0.001). Detailed investigation determined that there was no significant heterogeneity between the studies (I2=38.81, and p-value of the Q test=0.179). However, according to Egger\'s test, the study showed publication bias (p=0.035). This study found that bazedoxifene is a promising treatment option for endometriosis in animal models. However, more research on animals and humans is required to confirm these results.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    背景和目的:本研究综述了脂肪组织来源的可注射治疗骨关节炎(OA)动物模型的最新趋势,专注于最低限度地操纵或轻度处理的脂肪组织。通过评估和检查在不同的动物OA模型中研究这些疗法的特定背景,这篇综述旨在提供有价值的见解,这些见解将为未来的研究和临床应用提供信息和指导,以持续寻求骨关节炎的有效治疗方法。材料和方法:本研究对PubMed和Embase进行了全面的文献综述,以确定使用动物模型研究的骨关节炎的最小操作脂肪组织来源的可注射疗法的研究。主要搜索找到530个结果。在排除关注自发性骨关节炎的文章后;在转染时,预处理,培养,或共培养的脂肪干细胞;以及全文不可用的文章,我们在评论中包含了11篇文章。结果:所检查的疗法包括通过胶原酶消化和离心获得的机械微破碎脂肪组织(MFAT)和基质血管部分(SVF)。这些干预措施在各种动物模型中进行了评估,包括老鼠,老鼠,兔子,和诱发OA的绵羊。值得注意的是,更多的研究集中在手术诱导的OA,而不是化学诱导的OA。对这些疗法的评估集中在阐明其保护性免疫调节,抗炎,和软骨再生潜力通过综合评估,包括宏观评估,组织学分析,免疫组织化学检查,和生化化验。结论:这篇综述提供了对不同动物模型中脂肪组织来源的骨关节炎可注射疗法的综合分析。在揭示潜在好处和见解的同时,数据的异质性和研究数量有限,突出表明需要进一步研究,为临床应用制定结论性建议.
    Background and Objectives: This scoping review investigates recent trends in adipose tissue-derived injectable therapies for osteoarthritis (OA) in animal models, focusing on minimally manipulated or lightly processed adipose tissue. By evaluating and examining the specific context in which these therapies were investigated across diverse animal OA models, this review aims to provide valuable insights that will inform and guide future research and clinical applications in the ongoing pursuit of effective treatments for osteoarthritis. Materials and Methods: This research conducted a comprehensive literature review of PubMed and Embase to determine studies about minimally manipulated adipose tissue-derived injectable therapies for osteoarthritis investigated using animal models. The primary search found 530 results. After excluding articles that focused on spontaneous osteoarthritis; on transfected, preconditioned, cultured, or co-cultured adipose-derived stem cells; and articles with unavailable full text, we included 11 articles in our review. Results: The examined therapies encompassed mechanical micro-fragmented adipose tissue (MFAT) and stromal vascular fraction (SVF) obtained via collagenase digestion and centrifugation. These interventions were evaluated across various animal models, including mice, rats, rabbits, and sheep with induced OA. Notably, more studies concentrated on surgically induced OA rather than chemically induced OA. The assessment of these therapies focused on elucidating their protective immunomodulatory, anti-inflammatory, and chondroregenerative potential through comprehensive evaluations, including macroscopic assessments, histological analyses, immunohistochemical examinations, and biochemical assays. Conclusions: This review provides a comprehensive analysis of adipose tissue-derived injectable therapies for osteoarthritis across diverse animal models. While revealing potential benefits and insights, the heterogeneity of data and the limited number of studies highlight the need for further research to formulate conclusive recommendations for clinical applications.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    这篇叙述性综述旨在研究植物提取物在预防和治疗脱发(秃发)方面的治疗潜力和作用机制。我们搜索并选择了与脱发有关的植物提取物的研究论文,头发生长,或者头发再生,全面比较疗效,植物化学成分,和植物提取物的调节目标。这些研究表明,各种植物提取物在体外增加了毛乳头细胞的存活和增殖,体外毛囊中细胞增殖和毛发生长增强,并促进体内动物模型中的毛发生长或再生。在临床试验中验证了几种植物提取物的促进毛发生长的功效。一些酚类化合物,萜类和萜类化合物,含硫化合物,和脂肪酸被鉴定为植物提取物中含有的活性化合物。植物提取物及其活性化合物的药理作用与促进细胞存活有关,细胞增殖,或细胞周期进程,以及几种生长因子的上调,如IGF-1,VEGF,HGF,和KGF(FGF-7),导致毛发周期中生长期的诱导和延伸。这些作用也与氧化应激的缓解有关,炎症反应,细胞衰老,或凋亡,以及雄性激素及其受体的下调,防止进入毛发周期的静止期。几种活性植物提取物和植物化学物质刺激蛋白激酶B(PKB,也称为AKT),细胞外信号调节激酶(ERK),无翼和Int-1(WNT),或声波刺猬(SHH),同时抑制转化生长因子(TGF)-β或骨形态发生蛋白(BMP)介导的其他细胞信号通路。因此,精心挑选的植物提取物及其活性化合物可以对头发健康产生有益的影响。有人提出,针对上述细胞事件和细胞信号传导途径的植物化学物质的发现将促进针对脱发的新靶向疗法的开发。
    This narrative review aims to examine the therapeutic potential and mechanism of action of plant extracts in preventing and treating alopecia (baldness). We searched and selected research papers on plant extracts related to hair loss, hair growth, or hair regrowth, and comprehensively compared the therapeutic efficacies, phytochemical components, and modulatory targets of plant extracts. These studies showed that various plant extracts increased the survival and proliferation of dermal papilla cells in vitro, enhanced cell proliferation and hair growth in hair follicles ex vivo, and promoted hair growth or regrowth in animal models in vivo. The hair growth-promoting efficacy of several plant extracts was verified in clinical trials. Some phenolic compounds, terpenes and terpenoids, sulfur-containing compounds, and fatty acids were identified as active compounds contained in plant extracts. The pharmacological effects of plant extracts and their active compounds were associated with the promotion of cell survival, cell proliferation, or cell cycle progression, and the upregulation of several growth factors, such as IGF-1, VEGF, HGF, and KGF (FGF-7), leading to the induction and extension of the anagen phase in the hair cycle. Those effects were also associated with the alleviation of oxidative stress, inflammatory response, cellular senescence, or apoptosis, and the downregulation of male hormones and their receptors, preventing the entry into the telogen phase in the hair cycle. Several active plant extracts and phytochemicals stimulated the signaling pathways mediated by protein kinase B (PKB, also called AKT), extracellular signal-regulated kinases (ERK), Wingless and Int-1 (WNT), or sonic hedgehog (SHH), while suppressing other cell signaling pathways mediated by transforming growth factor (TGF)-β or bone morphogenetic protein (BMP). Thus, well-selected plant extracts and their active compounds can have beneficial effects on hair health. It is proposed that the discovery of phytochemicals targeting the aforementioned cellular events and cell signaling pathways will facilitate the development of new targeted therapies for alopecia.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    目的:本综述旨在概述和总结黄曲霉毒素的最新研究,通过描述自然的研究,草药和化学化合物在动物(猪)模型和体外细胞研究中的应用。黄曲霉毒素,一种致癌毒素代谢产物,是由黄曲霉在潮湿环境中产生的,对人类健康和作物生产构成威胁。目前的治疗包括防止接触黄曲霉毒素和抵消其有害毒性作用,能够对黄曲霉毒素解毒剂进行生存和研究。
    目的:总结当前的研究前景,概述黄曲霉毒素在农场生产中对动物饲草的影响,食品和作物加工。治疗黄曲霉毒素的补救措施的研究应用正在发展,以查明负责黄曲霉毒素影响传播和治疗作用的生化途径。
    结论:强调黄曲霉毒素对肉类和乳制品的环境压力;描述与黄曲霉毒素对人类健康相关的临床综合征,这些综合征被建议的治疗和预防性干预措施所抵消。了解如何在饲料条件下改善农场动物的健康。
    OBJECTIVE: The current review aims to outline and summarize the latest research on aflatoxin, with research studies describing natural, herbal and chemical compound applications in animal (pig) models and in vitro cellular studies. Aflatoxin, a carcinogenic toxin metabolite, is produced by Aspergillus flavus in humid environments, posing a threat to human health and crop production. The current treatment involves the prevention of exposure to aflatoxin and counteracting its harmful toxic effects, enabling survival and research studies on an antidote for aflatoxin.
    OBJECTIVE: To summarize current research prospects and to outline the influence of aflatoxin on animal forage in farm production, food and crop processing. The research application of remedies to treat aflatoxin is undergoing development to pinpoint biochemical pathways responsible for aflatoxin effects transmission and actions of treatment.
    CONCLUSIONS: To underline the environmental stress of aflatoxin on meat and dairy products; to describe clinical syndromes associated with aflatoxicosis on human health that are counteracted with proposed treatment and preventive interventions. To understand how to improve the health of farm animals with feed conditions.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    下背痛的常见原因之一是椎间盘退变(IDD),其次是椎间盘源性疼痛。与IDD的发病和进展相关的一些重要风险因素包括年龄,机械不平衡,营养和炎症的变化。根据最近的研究,建立了五种类型的动物模型来产生IDD:自发模型,穿刺模型,生物力学模型,化学模型和混合模型。这些模型对于研究和理解IDD的自然史以及确定IDD的潜在治疗目标至关重要。在我们的研究中,我们将讨论这些模型的技术方面,模型建立和可观察到的退化出现之间的时间,以及他们在各种研究中的潜力。应将每种动物模型与人类自然IDD发病机制进行比较,以指导该领域的未来研究工作。通过提高各种动物模型的知识和适当应用,我们寻求提高对这种疾病的认识和进一步的转化研究。
    One of the frequent causes of low back pain is intervertebral disc degeneration (IDD), which is followed by discogenic pain. Some significant risk factors that have been linked to the onset and progression of IDD include age, mechanical imbalance, changes in nutrition and inflammation. According to recent studies, five types of animal models are established for producing IDD: the spontaneous models, the puncture models, the biomechanical models, the chemical models and the hybrid models. These models are crucial in studying and understanding IDD\'s natural history and identifying potential treatment targets for IDD. In our study, we\'ll talk about the technical aspects of these models, the time between model establishment and the apparition of observable degradation, and their potential in various research. Each animal model should be compared to the human natural IDD pathogenesis to guide future research efforts in this area. By improving knowledge and appropriate application of various animal models, we seek to raise awareness of this illness and further translational research.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    背景:黄芪(AM)显示出治疗糖尿病肾病(DKD)的潜在治疗益处,无法治愈的肾衰竭的主要原因。然而,其对肾脏结局的综合影响和合理机制尚不清楚.
    目的:本系统综述和荟萃分析旨在综合AM对DKD动物模型肾脏结局的影响和机制。
    方法:搜索了7个电子数据库进行动物研究,直到2023年9月。基于SYRCLE的偏差风险工具评估偏差风险。标准化平均差(SMD)或平均差(MD)估计AM对血清肌酐(SCr)的影响,血尿素氮(BUN),白蛋白尿,组织学变化,氧化应激,炎症,纤维化和糖脂。使用随机效应模型汇集效应。异质性表示为I2。亚组分析调查了肾脏结局的治疗和动物相关因素。使用漏斗图和Egger检验评估发表偏倚。进行敏感性分析以评估结果的稳健性。采用RevMan5.3和StataMP15软件进行统计分析。
    结果:确定了涉及1543只动物的40项研究用于分析。AM治疗显着降低SCr(MD=-19.12μmol/l,95%CI:-25.02至-13.23),BUN(MD=-6.72mmol/l,95%CI:-9.32至-4.12),尿白蛋白排泄率(SMD=-2.74,95%CI:-3.57,-1.90),组织学改变(SMD=-2.25,95%CI:-3.19至-1.32)。AM处理显著改善抗氧化应激表达(SMD=1.69,95%CI:0.97~2.41),炎症生物标志物减少(SMD=-3.58,95%CI:-5.21至-1.95)。AM治疗也降低了纤维化标志物(即TGF-β1,CTGF,胶原蛋白IV,Wnt4和β-连环蛋白)和增加的抗纤维化标志物BMP-7。血糖,与DM对照组相比,血脂和肾脏大小也得到改善.
    结论:AM可通过多种信号通路改善肾脏预后,减轻肾脏损伤。这表明AM可能是开发未来DKD疗法的一种选择。
    BACKGROUND: Astragalus membranaceus (AM) shows potential therapeutic benefits for managing diabetic kidney disease (DKD), a leading cause of kidney failure with no cure. However, its comprehensive effects on renal outcomes and plausible mechanisms remain unclear.
    OBJECTIVE: This systematic review and meta-analysis aimed to synthesize the effects and mechanisms of AM on renal outcomes in DKD animal models.
    METHODS: Seven electronic databases were searched for animal studies until September 2023. Risk of bias was assessed based on SYRCLE\'s Risk of Bias tool. Standardized mean difference (SMD) or mean difference (MD) were estimated for the effects of AM on serum creatinine (SCr), blood urea nitrogen (BUN), albuminuria, histological changes, oxidative stress, inflammation, fibrosis and glucolipids. Effects were pooled using random-effects models. Heterogeneity was presented as I2. Subgroup analysis investigated treatment- and animal-related factors for renal outcomes. Publication bias was assessed using funnel plots and Egger\'s test. Sensitivity analysis was performed to assess the results\' robustness. RevMan 5.3 and Stata MP 15 software were used for statistical analysis.
    RESULTS: Forty studies involving 1543 animals were identified for analysis. AM treatment significantly decreased SCr (MD = -19.12 μmol/l, 95 % CI: -25.02 to -13.23), BUN (MD = -6.72 mmol/l, 95 % CI: -9.32 to -4.12), urinary albumin excretion rate (SMD = -2.74, 95 % CI: -3.57, -1.90), histological changes (SMD = -2.25, 95 % CI: -3.19 to -1.32). AM treatment significantly improved anti-oxidative stress expression (SMD = 1.69, 95 % CI: 0.97 to 2.41), and decreased inflammation biomarkers (SMD = -3.58, 95 % CI: -5.21 to -1.95). AM treatment also decreased fibrosis markers (i.e. TGF-β1, CTGF, collagen IV, Wnt4 and β-catenin) and increased anti-fibrosis marker BMP-7. Blood glucose, lipids and kidney size were also improved compared with the DM control group.
    CONCLUSIONS: AM could improve renal outcomes and alleviate injury through multiple signaling pathways. This indicates AM may be an option to consider for the development of future DKD therapeutics.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    关于快速眼动睡眠(REMS)在处理情绪中的重要性的证据正在积累。本系统综述的重点是实验性REMS剥夺(REMSD)的结果,这是REMSD动物模型和人体研究中最常见的方法。这篇综述显示,应用的REMSD方法存在很大差异。与人类研究相比,动物模型使用了更长的剥夺方案,主要报道了一夜后的急性剥夺效应。对动物模型的研究表明,REMSD引起攻击行为,增加疼痛敏感性,减少性行为,以及恐惧记忆的整合。动物模型还显示,在关键发育时期的REMSD会对情感相关行为产生持久的影响。少数人类研究显示疼痛敏感性增加,并表明REMSD后情感记忆的巩固更强。由于药物干预(如选择性5-羟色胺再摄取抑制剂[SSRIs])可能会长期抑制REMS,关于人类慢性REMS抑制的影响和机制的知识存在明显差距。
    Evidence on the importance of rapid-eye-movement sleep (REMS) in processing emotions is accumulating. The focus of this systematic review is the outcomes of experimental REMS deprivation (REMSD), which is the most common method in animal models and human studies on REMSD. This review revealed that variations in the applied REMSD methods were substantial. Animal models used longer deprivation protocols compared with studies in humans, which mostly reported acute deprivation effects after one night. Studies on animal models showed that REMSD causes aggressive behavior, increased pain sensitivity, reduced sexual behavior, and compromised consolidation of fear memories. Animal models also revealed that REMSD during critical developmental periods elicits lasting consequences on affective-related behavior. The few human studies revealed increases in pain sensitivity and suggest stronger consolidation of emotional memories after REMSD. As pharmacological interventions (such as selective serotonin reuptake inhibitors [SSRIs]) may suppress REMS for long periods, there is a clear gap in knowledge regarding the effects and mechanisms of chronic REMS suppression in humans.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    牛皮癣表现为一种复杂的遗传性皮肤病,以浸润的免疫细胞和角质形成细胞之间的相互作用为特征。在理解编码和非编码基因的分子机制方面取得了实质性进展。这对临床治疗方法产生了积极影响。尽管对银屑病发病机制的遗传方面进行了广泛的研究,充分掌握其表观遗传成分仍然是一项具有挑战性的工作。为了应对对缓解炎症性皮肤病的创新治疗方法的迫切需求,各种新颖的策略正在考虑之中。这些包括使用反义核苷酸的基因治疗,沉默RNA复合物,干细胞疗法,和基于抗体的治疗。迫切需要复制人牛皮癣的牛皮癣样动物模型,以促进这些新疗法的早期临床前评估。作者对银屑病研究中使用的不同银屑病样动物模型中的各种基因治疗进行了全面综述。列入名单的动物接受了皮肤治疗,如咪喹莫特的应用,以及遗传和生物注射,这些干预措施的结果是详细的。动物模型在将药物发现从实验室转化为临床实践中起着至关重要的作用。这些模型有助于提高临床前数据的可重复性和临床适用性。许多具有与人类牛皮癣相似特征的动物模型已被证明可用于理解牛皮癣的发展。在这次审查中,本文重点介绍了基于RNA的基因治疗在不同类型银屑病样动物模型中的探索,以提高银屑病的治疗效果。
    Psoriasis presents as a complex genetic skin disorder, characterized by the interaction between infiltrated immune cells and keratinocytes. Substantial progress has been made in understanding the molecular mechanisms of both coding and non-coding genes, which has positively impacted clinical treatment approaches. Despite extensive research into the genetic aspects of psoriasis pathogenesis, fully grasping its epigenetic component remains a challenging endeavor. In response to the pressing demand for innovative treatments to alleviate inflammatory skin disorders, various novel strategies are under consideration. These include gene therapy employing antisense nucleotides, silencing RNA complexes, stem cell therapy, and antibody-based therapy. There is a pressing requirement for a psoriasis-like animal model that replicates human psoriasis to facilitate early preclinical evaluations of these novel treatments. The authors conduct a comprehensive review of various gene therapy in different psoriasis-like animal models utilized in psoriasis research. The animals included in the list underwent skin treatments such as imiquimod application, as well as genetic and biologic injections, and the results of these interventions are detailed. Animal models play a crucial role in translating drug discoveries from the laboratory to clinical practice, and these models aid in improving the reproducibility and clinical applicability of preclinical data. Numerous animal models with characteristics similar to those of human psoriasis have proven to be useful in understanding the development of psoriasis. In this review, the article focuses on RNA-based gene therapy exploration in different types of psoriasis-like animal models to improve the treatment of psoriasis.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    背景:使用适当的动物模型进行癌症研究是一项重大挑战,特别是对于缺乏维持和使用异种移植动物或基因工程小鼠模型(GEMM)资源的研究人员。此外,几个打算纳入这些模式的国家必须进行进口程序,带来了额外的挑战。
    目的:这篇综述旨在探索在有限资源下使用细胞来源的同种异体移植或同基因模型。结果可供调查人员使用,特别是来自中低收入国家,有助于肺癌根除。
    方法:在各种数据库上进行了文献检索,包括PubMed,WebofScience,还有Scopus.此外,选定文章的出版年份设置在2013年至2023年之间,具有不同的搜索组件(SC),即肺癌(SC1),动物模型(SC2),和临床前研究(SC3)。
    结果:本系统综述集中于选择动物,细胞,和可用于产生同种异体移植型肺癌动物模型的方法来自101篇文章。
    结论:根据结果,在癌症研究中使用细胞来源的同种异体移植模型是可行和相关的,它提供了有关资源有限的条件的宝贵见解。
    BACKGROUND: The use of appropriate animal models for cancer studies is a major challenge, particularly for investigators who lack the resources to maintain and use xenograft animals or genetically engineered mouse models (GEMM). In addition, several countries intending to incorporate these models must conduct importation procedures, posing an additional challenge.
    OBJECTIVE: This review aimed to explore the use of cell-derived allograft or syngeneic models under limited resources. The results can be used by investigators, specifically from low-middle-income countries, to contribute to lung cancer eradication.
    METHODS: A literature search was carried out on various databases, including PubMed, Web of Science, and Scopus. In addition, the publication year of the selected articles was set between 2013 and 2023 with different search components (SC), namely lung cancer (SC1), animal models (SC2), and preclinical studies (SC3).
    RESULTS: This systematic review focused on selecting animals, cells, and methods that could be applied to generating allograft-type lung cancer animal models from 101 included articles.
    CONCLUSIONS: Based on the results, the use of cell-derived allograft models in cancer studies is feasible and relevant, and it provides valuable insights regarding the conditions with limited resources.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

公众号